Sign inJoin waitlistJoin the waitlist

EC

Emerson Chen

Assistant Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine · Oregon Health & Science University

Credentials: · · · · ·

History

Oregon Health & Science University
Present

Hematology and Medical Oncology
Oregon Health & Science University
2016–2019
Hospital of the University of Pennsylvania
2013–2016
Leonard M. Miller School of Medicine
2009–2013

Research

Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
JAMA Oncology · 2018 · 251 citations
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
The Lancet Oncology · 2023 · 226 citations
Estimation of Study Time Reduction Using Surrogate End Points Rather Than Overall Survival in Oncology Clinical Trials
JAMA Internal Medicine · 2019 · First of 4 authors · 129 citations

AK
Adel Kardosh
20 papers
CL
Charles Lopez
19 papers
Skye Mayo
13 papers
Vinay Prasad
12 papers
NN
Nima Nabavizadeh
11 papers
TS
Thomas Sutton
10 papers · 9 as a resident
RT
Rajat Thawani
7 papers · 5 as a fellow
Charles Thomas
6 papers
FR
Flavio Rocha
6 papers
GP
Guillaume Pegna
6 papers · 1 as a fellow
LT
Liana Tsikitis
6 papers
Aaron Grossberg
5 papers

Clinical trials

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2025–2027
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2027